Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tyler Robinson, Melody Pai, Jeff Liu, Frederick Vizeacoumar, Thomas Sun, Sean Egan, Alessandro Datti, Jing Huang & Eldad Zacksenhaus. (2013) High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: Interaction with IQ motif-containing factors. Cell Cycle 12:18, pages 3013-3024.
Read now
Read now
Articles from other publishers (34)
Mona Bahremani, Nadereh Rashtchizadeh, Mehdi Sabzichi, Amir Mansour Vatankhah, Sepideh Danaiyan, Haniyeh Poursistany, Jamal Mohammadian & Amir Ghorbanihaghjo. (2023) Enhanced chemotherapeutic efficacy of docetaxel in human lung cancer cell line via GLUT1 inhibitor. Journal of Biochemical and Molecular Toxicology 37:6.
Crossref
Crossref
Anupama Radhakrishnan, Pritha Roy, Krishnangshu B. Chowdhury, Ritam Joarder & Partha Dasgupta. (2023) The impact of pathological complete response on survival in patients with breast cancer and occurrence in different intrinsic subtypes: A retrospective observational study. Cancer Research, Statistics, and Treatment 6:2, pages 191-199.
Crossref
Crossref
Nhan Nguyen, Terezinha Souza, Jos Kleinjans & Danyel Jennen. (2022) Transcriptome analysis of long noncoding RNAs reveals their potential roles in anthracycline-induced cardiotoxicity. Non-coding RNA Research 7:2, pages 106-113.
Crossref
Crossref
Bahaa G.M. Youssif, Ahmed M. Gouda, Amr H. Moustafa, Antar A. Abdelhamid, Hesham A.M. Gomaa, Islam Kamal & Adel A. Marzouk. (2022) Design and synthesis of new triarylimidazole derivatives as dual inhibitors of BRAFV600E/p38α with potential antiproliferative activity. Journal of Molecular Structure 1253, pages 132218.
Crossref
Crossref
Olamide M. Olawoyin, Sumarth Mehta, Fouad Chouairi, Kyle S. Gabrick, Tomer Avraham, Lajos Pusztai & Michael Alperovich. (2021) Comparison of Autologous Breast Reconstruction Complications by Type of Neoadjuvant Chemotherapy Regimen. Plastic & Reconstructive Surgery 148:6, pages 1186-1196.
Crossref
Crossref
Nhan Nguyen, Terezinha Souza, Marcha C. T. Verheijen, Hans Gmuender, Nathalie Selevsek, Ralph Schlapbach, Jos Kleinjans & Danyel Jennen. (2021) Translational Proteomics Analysis of Anthracycline-Induced Cardiotoxicity From Cardiac Microtissues to Human Heart Biopsies. Frontiers in Genetics 12.
Crossref
Crossref
Robert RoskoskiJr.Jr.. (2021) Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs). Pharmacological Research 165, pages 105422.
Crossref
Crossref
Mona Pathak, Suryanarayana VS Deo, Sada Nand Dwivedi, Bhaskar Thakur, Vishnubhatla Sreenivas & Goura Kishore Rath. (2020) Regimens of neo-adjuvant chemotherapy in the treatment of breast cancer: A systematic review & network meta-analysis with PRISMA-NMA compliance. Critical Reviews in Oncology/Hematology 153, pages 103015.
Crossref
Crossref
Jinju Lee, Young Jae Cho, Jeong-Won Lee & Hyung Jun Ahn. (2020) KSP siRNA/paclitaxel-loaded PEGylated cationic liposomes for overcoming resistance to KSP inhibitors: Synergistic antitumor effects in drug-resistant ovarian cancer. Journal of Controlled Release 321, pages 184-197.
Crossref
Crossref
Jingjing Li, Yihan Wu, Di Wang, Liang Zou, Chaomei Fu, Jinming Zhang & George Pak-Heng Leung. (2019) Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects. Pharmacological Research 146, pages 104313.
Crossref
Crossref
Marijn T.M. van Jaarsveld, Difan Deng, Erik A.C. Wiemer & Zhike Zi. (2019) Tissue-Specific Chk1 Activation Determines Apoptosis by Regulating the Balance of p53 and p21. iScience 12, pages 27-40.
Crossref
Crossref
Robert RoskoskiJr.Jr.. (2019) Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers. Pharmacological Research 139, pages 395-411.
Crossref
Crossref
Fatemeh khaki-khatibi, Marjan Ghorbani, Mehdi Sabzichi, Fatemeh Ramezani & Jamal Mohammadian. (2019) Adjuvant therapy with stattic enriches the anti-proliferative effect of doxorubicin in human ZR-75-1 breast cancer cells via arresting cell cycle and inducing apoptosis. Biomedicine & Pharmacotherapy 109, pages 1240-1248.
Crossref
Crossref
Mona Pathak, Sada Nand Dwivedi, S. V. S. Deo, Bhaskar Thakur, Vishnubhatla Sreenivas & G. K. Rath. (2018) Neoadjuvant chemotherapy regimens in treatment of breast cancer: a systematic review and network meta-analysis protocol. Systematic Reviews 7:1.
Crossref
Crossref
Sanhong Liu, Zifeng Wang, Zukai Liu, Shuo Shi, Zhaoran Zhang, Jiawei Zhang & Haifan Lin. (2018) miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer. Journal of Molecular Cell Biology 10:4, pages 302-315.
Crossref
Crossref
Simona Pavan, Nathalie Meyer-Schaller, Maren Diepenbruck, Ravi Kiran Reddy Kalathur, Meera Saxena & Gerhard Christofori. (2018) A kinome-wide high-content siRNA screen identifies MEK5–ERK5 signaling as critical for breast cancer cell EMT and metastasis. Oncogene 37:31, pages 4197-4213.
Crossref
Crossref
Bahare Salehi, Paolo Zucca, Mehdi Sharifi-Rad, Raffaele Pezzani, Sadegh Rajabi, William N. Setzer, Elena Maria Varoni, Marcello Iriti, Farzad Kobarfard & Javad Sharifi-Rad. (2018) Phytotherapeutics in cancer invasion and metastasis. Phytotherapy Research 32:8, pages 1425-1449.
Crossref
Crossref
Jamal Mohammadian, Ommoleila Molavi, Mohammad Bagher Pirouzpanah, Ali Akbar Rahim Rahimi & Nasser Samadi. (2018) Stattic enhances the anti-proliferative effect of docetaxel via the Bax/Bcl-2/cyclin B axis in human cancer cells. Process Biochemistry 69, pages 188-196.
Crossref
Crossref
Nulgumnalli Manjunathaiah Raghavendra, Divya Pingili, Sundeep Kadasi, Akhila Mettu & S.V.U.M. Prasad. (2018) Dual or multi-targeting inhibitors: The next generation anticancer agents. European Journal of Medicinal Chemistry 143, pages 1277-1300.
Crossref
Crossref
Paulo Michel Pinheiro Ferreira & Cláudia Pessoa. (2017) Molecular biology of human epidermal receptors, signaling pathways and targeted therapy against cancers: new evidences and old challenges. Brazilian Journal of Pharmaceutical Sciences 53:2.
Crossref
Crossref
Kari R. Fischer, Anna Durrans, Sharrell Lee, Jianting Sheng, Fuhai Li, Stephen T. C. Wong, Hyejin Choi, Tina El Rayes, Seongho Ryu, Juliane Troeger, Robert F. Schwabe, Linda T. Vahdat, Nasser K. Altorki, Vivek Mittal & Dingcheng Gao. (2015) Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527:7579, pages 472-476.
Crossref
Crossref
Céline Callens, Marc Debled, Marc Delord, Isabelle Turbiez-Stalain, Corinne Veyret, Ivan Bièche & Etienne Brain. (2015) High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial. Breast Cancer Research and Treatment 153:2, pages 383-389.
Crossref
Crossref
Wei Cao, Ying Liu, Ran Zhang, Bo Zhang, Teng Wang, Xianbing Zhu, Lin Mei, Hongbo Chen, Hongling Zhang, Pinghong Ming & Laiqiang Huang. (2015) Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells. Scientific Reports 5:1.
Crossref
Crossref
Xing Chen, Biao Ren, Ming Chen, Ming-Xi Liu, Wei Ren, Quan-Xin Wang, Li-Xin Zhang & Gui-Ying Yan. (2014) ASDCD: Antifungal Synergistic Drug Combination Database. PLoS ONE 9:1, pages e86499.
Crossref
Crossref
Robert RoskoskiJr.Jr.. (2014) The ErbB/HER family of protein-tyrosine kinases and cancer. Pharmacological Research 79, pages 34-74.
Crossref
Crossref
Nik Soriani Yaacob, Agustine Nengsih & Mohd. Nor Norazmi. (2013) Tualang Honey Promotes Apoptotic Cell Death Induced by Tamoxifen in Breast Cancer Cell Lines. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-9.
Crossref
Crossref
Tingyan Liu, Huaguang Peng, Meixia Zhang, Yihui Deng & Zhenghu Wu. (2010) Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin. European Journal of Pharmacology 641:1, pages 15-22.
Crossref
Crossref
Guo-qing Chen, Zhen-wei Yao, Wei-ping Zheng, Li Chen, Hong Duan & Yi Shen. (2010) Combined antitumor effect of ursolic acid and 5-fluorouracil on human esophageal carcinoma cell Eca-109 in vitro. Chinese Journal of Cancer Research 22:1, pages 62-67.
Crossref
Crossref
Nagi S. El Saghir, Alexandru Eniu, Robert W. Carlson, Zeba Aziz, Daniel Vorobiof & Gabriel N. Hortobagyi. (2008) Locally advanced breast cancer. Cancer 113:S8, pages 2315-2324.
Crossref
Crossref
Natalia Vykhodtseva, Nathan McDannold & Kullervo Hynynen. (2008) Progress and problems in the application of focused ultrasound for blood–brain barrier disruption. Ultrasonics 48:4, pages 279-296.
Crossref
Crossref
V Adamo, V Lorusso, R Rossello, B Adamo, G Ferraro, D Lorusso, G Condemi, D Priolo, L Di Lullo, A Paglia, S Pisconti, G Scambia & G Ferrandina. (2008) Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study. British Journal of Cancer 98:12, pages 1916-1921.
Crossref
Crossref
Tingyan Liu, Meixia Zhang, Hongliang Zhang, Chunyan Sun, Xiaolin Yang, Yihui Deng & Wenyue Ji. (2008) Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer. European Journal of Pharmacology 587:1-3, pages 78-84.
Crossref
Crossref
Gillian Whitaker, Amy Lillquist, Stephanie A. Pasas, Robert O'Connor, Fiona Regan, Craig E. Lunte & Malcolm R. Smyth. (2008) CE‐LIF method for the separation of anthracyclines: Application to protein binding analysis in plasma using ultrafiltration. Journal of Separation Science 31:10, pages 1828-1833.
Crossref
Crossref
Margaret S. Lee, Lisa Johansen, Yanzhen Zhang, Amy Wilson, Mitchell Keegan, William Avery, Peter Elliott, Alexis A. Borisy & Curtis T. Keith. (2007) The Novel Combination of Chlorpromazine and Pentamidine Exerts Synergistic Antiproliferative Effects through Dual Mitotic Action. Cancer Research 67:23, pages 11359-11367.
Crossref
Crossref